# Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer

> **NCT01781403** · PHASE1 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 22 (actual)

## Conditions studied

- Rectal Cancer

## Interventions

- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT01781403
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-10
- **Primary completion:** 2014-09-03
- **Final completion:** 2016-05-04
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2021-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01781403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01781403, "Preoperative CRT With Temozolomide Plus Capecitabine in Rectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01781403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*